Article
Impact of APOE ε4 Genotype Load on Cognitive Function and Lipid Metabolism in Patients With Cerebral Small Vessel Disease.
Annals of clinical and translational neurology - 1 Mar 2026
Jin Tingru, Yang Haocheng, Liu Feng, Lin Sihao, Hu Junru, Wang Jian, Gou Yulan
Abstract excerpt
BACKGROUND: Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and dyslipidemia in CSVD patients, and to explore whether lipid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
